Vanda Pharmaceuticals | VNDA - Market Capitalization


Vanda Pharmaceuticals reported $392.4M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
Akebia Therapeutics USD 312M 115M Mar/2026
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Anika Therapeutics USD 210M 71M Mar/2026
Arrowhead Research USD 9.02B 4.25B Dec/2025
AstraZeneca USD 220.14B 68B Mar/2026
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Esperion Therapeutics USD 475M 410M Mar/2026
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Heron Therapeutics USD 133M 105M Mar/2026
Insmed USD 37.12B 6.68B Dec/2025
J&J USD 500.24B 67.44B Dec/2025
Lexicon Pharmaceuticals USD 416M 2M Mar/2026
Merck USD 261.26B 51.62B Dec/2025
Novartis USD 303.66B 40.58B Mar/2026
Pfizer USD 153.96B 12.4B Mar/2026
PTC Therapeutics USD 6.1B 1.22B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Takeda JPY 7.64T 774.9B Dec/2025
Teva Pharmaceutical Industries USD 36.42B 14.06B Dec/2025
Ultragenyx Pharmaceutical USD 2.22B 680M Dec/2025
Vanda Pharmaceuticals USD 279M 6M Dec/2024
Veracyte USD 3.33B 627M Dec/2025